When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, researchers report. The detailed insights into cancer ...

Medically reviewed by Marla Anderson, MD Multiple myeloma is a type of blood cancer that forms in plasma cells, white blood ...

During a Case-Based Roundtable® event, Muhammad Umair Mushtaq, MD, discussed managing long-term toxicity concerns related to ...

A research team from the Heidelberg Medical Faculty, the German Cancer Research Center (DKFZ), the Berlin Institute of Health ...

Throughout my experience with multiple myeloma, I was humbled by the unexpected support and kindness shown to me.

Researchers sought to determine whether teclistamab would lead to a clinical response in patients with relapsed/refractory multiple myeloma.

Researchers discover that bone marrow cancer cells diversify drastically when exiting the bone marrow, which also affects the ...

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response ...

Bone disease is a hallmark of multiple myeloma (MM), associated with bone ... It correlates with quality of life and survival. Osteolytic bone lesions are the result of excessive bone resorption ...

Kyprolis is used in adults to treat relapsed or refractory multiple myeloma in certain situations. (“Relapsed” means the cancer returned after past treatments. “Refractory” means the ...

Multiple myeloma (also referred to as myeloma) is a type of rare, incurable cancer of the blood—also known as hematologic cancer. It affects cells called plasma cells, which are types of white blood ...